37
Participants
Start Date
June 4, 2014
Primary Completion Date
September 13, 2016
Study Completion Date
September 13, 2016
Placebo
Placebo
PF-06342674 Dose A
Multiple SC Doses
PF-06342674 Dose B
Multiple SC Doses
PF-06342674 Dose C
Multiple SC Doses
PF-06342674 Dose D
Multiple SC Doses
Duke Clinical Research Unit, Durham
Duke University Health Systems (DUHS) Investigational Drug Services, Durham
Atlanta Diabetes Associates, Atlanta
University Of Minnesota Fairview Pharmacy Services, Minneapolis
University Of Minnesota Medical School, Minneapolis
Duchossois Center for Advanced Medicine, Chicago
The University of Chicago Medical Center, Chicago
University of Chicago Clinical Resource Center, Chicago
University of Chicago Medical Center, Chicago
Barnes- Jewish HOSP Att: Kathryn Vehe, St Louis
Washington University - Center for Advanced Medicine, St Louis
Washington University, St Louis
Barbara Davis Center, Aurora
VA San Diego Healthcare System (Drug Shipment), San Diego
Veterans Administration San Diego Healthcare System, San Diego
University of California, San Francisco, San Francisco
Yale School of Medicine, New Haven
Yale New Haven Hospital - Investigational Drug Services, New Haven
Yale University School of Medicine, New Haven
Umass Memorial Medical Center, Worcester
University of Massachusetts Medical School, Worcester
Lead Sponsor
Pfizer
INDUSTRY